In 2003, Michael Friebe PhD launched the holding company TOMOVATION (neatly combining tomography and innovation). Back in 1993, Dr Friebe was the founder of Neuromed AG, which at the time was the biggest provider and seller of mobile diagnostic services and refurbished MRI and CT systems in Central Europe. This firm was subsequently bought by UMS AG.
After previous meetings in the USA (2002) and Japan (2004), this October the 3rd International Workshop of Pulmonary Functional Imaging (IWPFI) took place in the German Cancer Research Centre, based in Heidelberg University, Germany. " 'The clinicians' need for earlier and more detailed diagnosis in pulmonary disease demands a joint interdisciplinary effort to push the limits in pulmonary…
The value of diffusion-weighted and diffusion tensor imaging techniques.
High-resolution tomographic scanners and other 3-D technologies provide a number of compelling advantages for diagnostic medical imaging.
Medtron AG is a leading European designer, manufacturer and distributor of contrast agent injectors used for CT, MRI and Angiography.
Guidelines updated for high-risk women aged between 20-49 years.
Infants born very prematurely have a high probability of experiencing behavioural and neuro-cognitive impairments during childhood and adolescence.
Surgery is no longer the automatic choice to eradicate malignant tumours.
Ideal solution for paediatric neurological and orthopaedic imaging.
Professor Raimung Erbel, of the West GErman Heart Centre Esse, Duisburg University Hospital aobut the hot topics of this years´congress.
By Professor Maximilian F Reiser, director of the Institute of Clinical Radiology at the University Clinic, Munich, Germany
MORTIS is a new teleradiology system which utilises high-resolution laptops to receive images for diagnostic purposes.
At the 11th International MR Symposium radiologists were urged to co-ordinate a campaign to detect disease earlier, and a new 'tandem' concept for diagnosis and therapy was revealed.
In an interview with Daniela Zimmermann, Executive Director of European Hospital, Dr Mohammad Naraghi, Head of the Department of Business Development at Siemens Medical Solutions, discussed developments in moleculary medicine, biochips, preventive diagnostics and a comprehensive and integrated health system for the future.
Dr Hanns-Joachim Weinmann, Diagnostics and Radiopharmaceuticals, Magnetic Resonance Imaging & X-Ray Research, Schering AG, examines what is feasible and what still lies only at a tantalising distance.
12 distinguished researchers and industry representatives presented the latest molecular medicine research at the Molecular Medicine - from Diagnostics to Therapy symposium - one in a series of annual diagnostics seminars organised by the Forum Medicine Technology & Pharmaceutics e.V.
Dr Robert Krieg, Director of MR Molecular Imaging at Siemens Medical Solutions, described, in an interview with Daniela Zimmermann of European Hospital, the limitations of physics and the potential clinical benefits of hybrid technology - and a hitherto hush-hush MRI-PET project
Generating targeting agents for diagnostics, prognostics and radiotherapy, by designing biochemically specific elements in contrast agents to be the targeting molecules attached to and carrying diagnostic or radiotherapeutic molecules to abnormal cells.
A report by Thomas H Magee.
The Society for Computer Applications in Radiology (SCAR) has undergone a name change. SCAR is now the Society for Imaging Informatics in Medicine (SIIM).
We asked radiologist Cyrille H Benoit MD, Director of the Bellevue Zurich Radiology Institute, about the group's choice of radiology equipment - particularly its PACS - and the rules of reimbursement in the Swiss healthcare system.
Prevention is better than cure - use the technology! A report from the 1st International High Tech in Medicine congress.
Late in November and into early December, as icy air streamed over the shores of Lake Michigan - affirming the nickname `windy city´ for Chicago - radiologists continued to immigrate here en masse for their biggest annual gathering. This year the Radiological Society of North America (RSNA) held its 91st annual meeting, parallel with the scientific congress and trade fair. The exhibition alone…
Researchers open up new opportunities for cellular and molecular MR imaging.
Medtron AG, which designs and markets high-performance contrast agent injectors for use in CT, MRI and angiography, constantly aims to meet the demands of the latest scanner generations and advancing medical requirements, along with patient comfort and cost effectiveness.